En español
NIDA

Menu

New INVEST Fellow Investigates Cognitive Enhancer

New INVEST Drug Abuse Research Fellow Sujung Yoon, M.D., Ph.D., South Korea, will spend 12 months under the mentorship of Perry F. Renshaw, F.M.D., Ph.D., M.B.A., The Brain Institute, University of Utah, to focus on the application of multinuclear magnetic resonance spectroscopy markers of brain health in response to treatment.

Dr. Yoon and Dr. Renshaw have already been working together evaluating the effects of citicoline and, based on their findings in methamphetamine-dependent adolescents, plan in the next year to assess the effects of citicoline as a cognitive enhancer for patients with methamphetamine dependence. Dr. Yoon will focus specifically on the application of multinuclear magnetic resonance spectroscopy markers of brain health in response to treatment.

This page was last updated February 2012

    Attention

    Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at

    Looking for Treatment?

    Use the SAMHSA Treatment Locator or 1-800-662-HELP.

    Helpline open during government shutdown

    Important Dates

    NIDA-IAS-ANRS

    Open December 8, 2013
    Close February 10, 2014

    NIDA International Program Fellowships

    Application Deadlines:
    Postdoctoral Fellowships:
    April 1

    Meetings

    November 2 - November 6, 2013
    Boston, Massachusetts, USA
    November 9 - November 13, 2013
    San Diego, California, USA
    January 15 - January 19, 2014
    San Antonio, Texas, USA